Excelse Bio is focused on improved formulation and delivery of injectable biotechnology products to change therapy, as we know it today. By compressing otherwise delicate drugs, it's possible to eliminate IV administration and make drug delivery as simple as a shot or small pump. For patients managing chronic illnesses, these robust formulations can improve patient experience with quickly self-administered therapies given safely at home. In research studies, concentrations of up to 250 mg/ml have been reached enabling a switch to small subcutaneous doses. Excelse technology can lower viscosity improving manufacturability and patient experience.
Looking for a particular Excelse Bio employee's phone or email?
The Excelse Bio annual revenue was $1 million in 2026.
1 people are employed at Excelse Bio.
Excelse Bio is based in Thousand Oaks, California.
The NAICS codes for Excelse Bio are [54171, 541714, 54, 5417, 541].
The SIC codes for Excelse Bio are [87, 873].